Association of TYRP1 with hypoxia and its correlation with patient outcome in uveal melanoma.
J JhaM K SinghL SinghN PushkerN LomiR MeelK ChosdolS SenS BakhshiRachna MeelPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2021)
Our findings indicate that TYRP1 can be used as a potential biomarker in the development of targeted therapy in UM. Further studies on melanogenesis markers associated with TYRP1 could provide us a better understanding in this field.